Essex Savings Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Essex Savings Bank’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$215K	Sell	433 -193	-31%	-$85.5K	0.05%	299
2026 Q1	$280K	Sell	626 -8	-1%	-$3.73K	0.06%	234
2025 Q4	$287K	Sell	634 -78	-11%	-$33.6K	0.06%	238
2025 Q3	$279K	Buy	712 +8	+1%	+$3.34K	0.06%	239
2025 Q2	$313K	Buy	704 +13	+2%	+$5.99K	0.07%	212
2025 Q1	$335K	Sell	691 -1	-0.1%	-$466	0.08%	199
2024 Q4	$279K	Buy	692 +15	+2%	+$6.95K	0.07%	219
2024 Q3	$315K	Buy	677 +75	+12%	+$36K	0.08%	208
2024 Q2	$282K	Buy	602 +76	+14%	+$33K	0.08%	204
2024 Q1	$214K	Hold	526	–	–	0.06%	245
2023 Q4	$214K	Buy	+526	New	+$194K	0.06%	245
2019 Q3	–	Sell	-638	Closed	-$117K	–	594
2019 Q2	$117K	Buy	638 +82	+15%	+$14.3K	0.04%	316
2019 Q1	$102K	Buy	556 +250	+82%	+$46.2K	0.06%	216
2018 Q4	$51K	Buy	+306	New	+$53K	0.03%	288

Other funds holding VRTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Essex Savings Bank's VRTX Position: Q2 2026 in Review

Essex Savings Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 31% in Q2 2026, selling an estimated $85.5K and leaving 433 shares worth $215K. The position accounts for 0.05% of the portfolio, ranked #299.

Essex Savings Bank first reported a position in VRTX in Q4 2018 and has held it in 14 quarters since. The position peaked at $335K in Q1 2025. 1,014 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Essex Savings Bank held 433 shares of Vertex Pharmaceuticals worth $215K as of Q2 2026.
Essex Savings Bank sold 193 Vertex Pharmaceuticals shares in Q2 2026, an estimated $85.5K.
Vertex Pharmaceuticals made up 0.05% of Essex Savings Bank's portfolio in Q2 2026, its #299 holding.
Essex Savings Bank first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 14 quarters since.
Essex Savings Bank's Vertex Pharmaceuticals position peaked at $335K in Q1 2025.
1,014 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Essex Savings Bank's 13F filing for Q2 2026, filed 23 Jul 2026.